18 Month MileStones
HealthPro Direct®
MensRx® • WomensRx® — National Telehealth Platform (DTC)
This presentation outlines the strategic deployment of a $250,000 Launch Investment over an 18-month period.
Our detailed roadmap highlights key milestones, capital allocation, and measurable outcomes, targeting Break-Even by Month 7–8 and 10,000+ Users by Month 18, positioning HealthPro Direct for Series A readiness.
18-Month Roadmap:
Capital Deployment & Milestones for Dual-Brand Telehealth
1
Phase 1: Initial Activation & Dual-Brand Launch (Months 1-3)
Capital Deployment & Investment Focus ($122,500 - $127,500 total):
  • Domain Acquisition: Allocate $35,000 - $40,000 for MensRx.com and securing other essential domains.
  • Website Builds: Invest $12,500 for both MensRx™ and WomensRx™ platforms via TFC Marketing.
  • Legal & Compliance: $7,500 for business formation, $2,500 for compliance retainer.
  • Technology Setup: $5,000 for NimbusRx integration.
  • Certification: $12,000 for LegitScript certification for both sites.
  • Initial Marketing: Allocate an initial $60,000 via TFC Marketing for digital acquisition.
  • Operational Overhead: $500/month for bookkeeping services.
Key Deliverables:
  • Legal: Business entity fully formed; compliance retainer secured.
  • Technology: MensRx.com and WomensRx.com websites fully built and integrated with NimbusRx (eRx/telehealth backend) and PharmacyHub (503B compounding).
  • Operations: BelugaHealth asynchronous medical visit system integrated ($30/consultation pay-per-visit model implemented).
  • Certification: LegitScript certification successfully obtained for both MensRx™ and WomensRx™.
  • Launch: Simultaneous market launch of MensRx™ and WomensRx™ telehealth brands.
  • Marketing: Initial digital acquisition campaigns active via TFC Marketing, targeting a Customer Acquisition Cost (CAC) of ~$65.
Expected Outcomes:
  • Full operational readiness and initial market penetration for both platforms.
  • Acquire 100-300 active users by Month 3.
2
Phase 2: Growth & Break-Even Achievement (Months 4-8)
Capital Deployment & Investment Focus: Continued allocation of the remaining $122,500 - $127,500 of the initial $250,000 activation investment, prioritizing marketing scale, product expansion, and operational optimization. Legal and bookkeeping retainers continue monthly.
Key Deliverables:
  • Marketing Optimization: Refinement and scaling of digital acquisition strategies via TFC Marketing to maintain a CAC of ~$65.
  • MensRx™ Product Expansion: Launch new service offerings including Testosterone Replacement Therapy (TRT), Hair Restoration (e.g., MinoxPlus, MinoxiPro Shampoo), Performance Peptides, Sexual Wellness solutions, and Advanced Skin & Hair Care.
  • WomensRx™ Product Expansion: Launch new service offerings including Libido Enhancement (e.g., GlowBido pen, GlowVido capsule), Hormone Balance Therapy, Menopause Support, Therapeutic Peptides, and Premium Skin & Hair Care.
  • Legal: Begin trademark and patent attorney engagement (initial $25,000 fee) for brand protection and intellectual property.
Expected Outcomes & Milestones:
  • Achieve 1,295 active users by Month 6.
  • Reach Break-Even Point between Month 7 and 8, demonstrating financial viability with 2,000-3,000 active users.
  • Generate approximately $180/user monthly revenue with a 70% net margin, validating the business model and efficient capital utilization.
3
Phase 3: Scaling & Omnichannel Expansion (Months 9-18)
Capital Deployment & Investment Focus: Strategic deployment of reinvested profits and future funding to sustain growth, capture market share, and trigger expansion into omnichannel healthcare. Continued operational overheads.
  • Physical Clinic Planning: Commence strategic planning for physical clinic launches (Months 9-12).
  • Physical Clinic Investment: Secure $275,000 investment for the first physical clinic (Months 12-15).
Key Deliverables:
  • User Acquisition & Retention: Implement advanced user acquisition and retention initiatives, leveraging data analytics from TFC Marketing.
  • Service & Technology Enhancement: Integrate new technology platforms or service lines to further enhance defensibility and user experience.
  • Omnichannel Strategy: Develop and initiate execution of omnichannel expansion, including the establishment of the first physical clinic.
Expected Outcomes & Milestones:
  • Achieve 4,052 active users by Month 9.
  • Attain 7,178 active users by Month 12.
  • Surpass 10,000+ active users by Month 18.
  • Establish a clear pathway to a defensible omnichannel healthcare platform.
  • Achieve readiness for Series A funding by demonstrating significant user growth, sustained profitability, and strategic expansion.
18-Month Roadmap:
Deploying $250,000 for Rapid Activation & Growth
Foundational Milestone (Pre-Investment)
Our core technology stack, pharmacy partnerships, and compliance frameworks are already operational and thoroughly tested, ready for deployment.
Month 0-3: Rapid Deployment & Activation
Initial capital immediately unlocks domain acquisition, website builds, and marketing activation for MensRx™ and WomensRx™.
Month 4-18: Scaled Growth & Proven Economics
Measurable outcomes include CAC-funded customer acquisition driving compounding revenue with 90–95% retention rates, targeting Series A readiness.
The $250,000 investment serves as the critical fuel to activate our pre-built infrastructure, accelerating our 18-month roadmap. This capital deployment specifically enables: domain acquisition for MensRx.com, complete website development for both brands, full integration of telehealth and pharmacy workflows, establishment of a comprehensive compliance and trademark foundation, and initiation of CAC-funded customer acquisition. These precise investments are projected to generate rapid compounding revenue and industry-leading retention rates, charting a clear path to break-even by Month 7–8 and preparing the company for a Series A funding round within 18 months.
18-Month Roadmap:
Strategic Capital Deployment for Rapid Growth
Our $250,000 investment is precisely allocated across an 18-month timeline, focusing on critical milestones to achieve Series A readiness. This detailed plan ensures maximum efficiency in deploying capital for infrastructure, legal foundations, and sustained customer acquisition, leading to compounding revenue growth and measurable outcomes at every phase.
Months 1-3: Foundation & Launch (Initial $150,000)
  • MensRx.com Domain Acquisition ($35,000–$40,000) — Secured premium digital storefront.
  • TFC Website Builds (Both Brands) ($12,500) — Fully operationalized sales platforms.
  • Trademark/Patent Attorney ($25,000) — Established core IP protection.
  • Business Formation Attorney ($7,500) — Solid legal entity established.
  • Compliance Attorney Retainer ($2,500) — Ensured regulatory adherence from day one.
  • NimbusRx Platform Setup ($5,000) — Integrated telehealth & pharmacy workflows.
  • LegitScript Certification (2 Sites) ($12,000) — Achieved industry standard for online pharmacies.
  • Initial Customer Acquisition Budget ($60,000) — Commenced profitable customer acquisition with immediate feedback loops.
Months 4-12: Scaling & Optimization (Additional $75,000)
  • Continued Customer Acquisition ($50,000 allocation) — Scaled profitable marketing channels and expanded reach.
  • BelugaHealth (Pay-per-visit model) — Maintained high-quality telehealth consultations.
  • Professional Bookkeeping ($500/month) — Ensured robust financial tracking and reporting.
  • Product & Service Enhancements ($15,000) — Introduced new features based on customer feedback and market demand.
  • Operating Reserve ($10,000) — Maintained liquidity for unforeseen opportunities or challenges.
Months 13-18: Growth & Series A Readiness (Remaining $25,000)
  • Strategic Market Expansion ($15,000) — Explored new geographies or product lines for accelerated growth.
  • Advanced Data Analytics ($5,000) — Implemented tools for deeper insights into customer behavior and market trends.
  • Series A Preparation ($5,000) — Engaged consultants and refined financial models for next funding round.
  • Sustained Customer Acquisition & Operations — Continued profitable customer growth, high retention (90-95%), and optimized operational efficiency.
  • Operating Reserve — Managed remaining balance for working capital and strategic initiatives.
This capital structure is designed for maximum efficiency, with one-time investments in brand assets and legal infrastructure completed early, coupled with variable costs that scale with revenue. The marketing budget is structured to acquire customers profitably from day one, with immediate feedback loops for optimization, demonstrating a clear path to generating rapid compounding revenue with industry-leading retention rates and achieving Series A readiness within 18 months.
18-Month Vendor Integration & Capital Deployment Roadmap
Our strategy is built on a phased integration of best-in-class vendors, ensuring precise capital deployment to achieve critical milestones and position us for a successful Series A.
Months 1-3: Foundational Setup & Legal Framework
Initial capital deployment for core infrastructure and compliance:
  • NimbusRx Platform Setup: Full implementation of telehealth infrastructure managing e-prescriptions and patient journey automation. (Initial investment: $5,000)
  • TFC Website Builds: Launch of MensRx.com and sister brand platforms. (Initial investment: $12,500)
  • Legal & Compliance: Establish all necessary legal entities, trademarks, and initial compliance certifications. (Initial investment: ~$75,000 including domain, attorney fees, LegitScript)
Outcome: Fully operational digital storefronts and telehealth backend, legally compliant and ready for patient engagement.
Months 4-9: Service Launch & Initial Patient Acquisition
Strategic deployment of capital into patient-facing services and initial marketing efforts:
  • BelugaHealth Integration: Activation of our asynchronous medical provider network, enabling scalable and cost-effective consultations across all 50 states. (Pay-per-visit model: $30/consultation)
  • PharmacyHub Operationalization: Finalizing supply chain for proprietary compounding services, ensuring product availability for key therapeutic areas (hormones, peptides, etc.).
  • TFC Marketing Launch: Initial customer acquisition campaigns focusing on efficient CAC and LTV optimization. (Initial marketing allocation: $60,000)
Outcome: Live patient consultations and prescription fulfillment, with initial marketing driving measurable patient growth and revenue generation.
Months 10-18: Growth Acceleration & Series A Readiness
Continued investment in marketing and operational scaling, leveraging established vendor relationships for exponential growth:
  • Optimized Customer Acquisition: TFC Marketing refines campaigns based on performance data, expanding reach while maintaining profitability targets.
  • Expanded Service Offerings: PharmacyHub introduces additional proprietary formulations based on market demand.
  • Scalable Consultations: BelugaHealth network expands to meet increasing patient volume, ensuring service quality.
  • Operating Reserve Utilization: Remaining balance deployed as working capital to support operational scaling and sustain growth trajectory.
Outcome: Strong patient base, proven unit economics, and a robust operational framework demonstrating readiness for Series A funding, targeting significant revenue milestones.
18-Month Roadmap: Strategic Deployment for Product & Revenue Growth
Our 18-month roadmap outlines precise capital deployment and milestone achievements, positioning us for Series A readiness through targeted product expansion and revenue ecosystem optimization.
Phase 1: Foundation & Acquisition (Months 1-6)
Capital Deployment: Focus on optimizing existing MensRx™ & WomensRx™ portfolios for enhanced user acquisition.
Completion Goals:
  • Solidify supply chain for MinoxPlus® and GlowBido™.
  • Implement initial patient journey automation for improved conversion.
Measurable Outcomes: Achieve $150–220 Average Recurring Revenue (ARR) per customer, setting the baseline for growth.
Phase 2: Product Deepening & Scale (Months 7-12)
Capital Deployment: Invest in R&D for new formulations and scaling marketing efforts.
Completion Goals:
  • Launch new MensRx™ (Testosterone, Peptides, ED solutions) & WomensRx™ (Peptide protocols, Menopause management) offerings.
  • Expand telehealth network capacity for increased consultations.
Measurable Outcomes: Drive customer Lifetime Value (LTV) towards ~$2,000 by cross-selling and enhancing retention.
Phase 3: Market Leadership & Series A Readiness (Months 13-18)
Capital Deployment: Maximize market penetration and prepare for significant institutional funding.
Completion Goals:
  • Refine all advanced hair & skin formulations for both portfolios.
  • Implement advanced analytics for customer behavior and retention.
Measurable Outcomes: Sustain 90–95% Retention Rate and demonstrate clear path to market leadership, achieving Series A metrics.
18-Month Roadmap: Capital Deployment for Acquisition & Growth
Our robust unit economics underpin a clear 18-month milestone-driven roadmap, detailing how capital is strategically deployed to achieve significant growth and position the company for Series A readiness.
~$65
Customer Acquisition Cost
Efficient digital marketing CAC
~$180
Average Order Value
Initial purchase value
~$125
Monthly Net Margin
Per active subscriber
90–95%
Monthly Retention
Compounding customer base
1
Months 1-6: Initial Capital Deployment & Validation
Investment Focus: Initial $100k-$120k for performance marketing, platform optimization, and initial team scaling.
Key Activities: Scale proven digital channels, A/B test new creatives, and refine onboarding flows. Focus on maintaining sub-$70 CAC.
Measurable Outcomes: Achieve consistent 90-95% monthly retention and positive unit economics from day one. Build initial subscriber base towards 1,000-2,000 active customers.
2
Months 7-12: Accelerated Growth & Expansion
Investment Focus: Deploy additional $80k-$100k into scaling marketing channels, product development for new features, and infrastructure improvements.
Key Activities: Expand into new geographic markets or niche segments. Introduce select new products/SKUs to increase AOV and LTV. Further optimize customer journey.
Measurable Outcomes: Expand active subscriber base to 3,000-5,000, with AOV maintained at ~$180 and monthly net margin at ~$125 per subscriber. Test new revenue streams.
3
Months 13-18: Strategic Scaling & Series A Readiness
Investment Focus: Final capital allocation of $30k-$50k for market leadership initiatives, strategic partnerships, and pre-Series A financial audit.
Key Activities: Consolidate market position, explore B2B opportunities or strategic partnerships. Prepare comprehensive data room and financial projections for Series A discussions.
Measurable Outcomes: By Month 18, reach 10,000+ active subscribers generating over $1.2 million in monthly net revenue. Demonstrate clear path to profitability and substantial LTV, proving Series A readiness.
This strategic deployment of approximately $250,000 over 18 months ensures a powerful compounding effect, transforming our efficient acquisition into a thriving, scalable business. Each phase is designed to build on the last, leveraging our strong customer economics to achieve the next significant milestone.
18-Month Strategic Roadmap & Capital Deployment
Our initial $250,000 capital infusion is strategically earmarked to fuel an aggressive 18-month growth roadmap, culminating in a Series A-ready enterprise. This chart visually outlines the projected user acquisition milestones directly tied to our capital deployment strategy. In the early months (0-3), proceeds will primarily fund the establishment of efficient digital acquisition channels and optimization of customer experience, resulting in our first 100 active users. By Month 6, sustained investment in marketing and product iteration enables us to reach a critical mass of 1,295 active users. The inflection point occurs between Months 7–8, as continued deployment of capital for growth initiatives helps us achieve operational break-even with approximately 2,000–3,000 users. From this point, growth accelerates exponentially due to our strong retention economics, with retained customers compounding our new acquisitions. By Month 18, maintaining a consistent acquisition rate of 1,500 new customers monthly, we will achieve our pivotal milestone of 10,000+ active users, demonstrating robust unit economics and market traction essential for our Series A round.
18-Month Milestone Roadmap: Revenue Scaling & Break-Even Analysis
This card details our 18-month milestone roadmap, demonstrating how initial capital deployment of $250,000 will drive our path to Series A readiness. Our subscription model generates $180 in monthly recurring revenue per active user, with approximately 70% flowing to net revenue after product costs, payment processing, and customer service. Each phase is designed to achieve specific measurable outcomes:
  • Months 1-6: Initial capital is deployed to establish efficient acquisition channels and optimize customer experience, laying the groundwork for user growth. By Month 7-8, we project reaching 2,000–3,000 active subscribers. This critical milestone signifies our break-even point, where monthly net revenue ($252,000 - $378,000 as per 1.5k to 3k user projection) exceeds our operating burn rate, making the business self-sustaining. Capital at this stage focuses on solidifying our product-market fit and retention.
  • Months 9-12: With sustained growth and capital reinvestment from generated net revenue, we aim to reach 5,000 active users. At this scale, we generate a significant $630,000 in monthly net revenue, providing substantial capital for continued reinvestment into product development and strategic market expansion. This phase demonstrates our ability to generate significant cash flow for organic growth.
  • Months 13-18: Leveraging our proven unit economics and reinvested profits, we drive towards our ultimate goal of 10,000+ active users by Month 18. This achievement is projected to yield $1.26 million in monthly net revenue, positioning us perfectly for Series A fundraising with demonstrated scale, strong financial performance, and a clear path to further expansion.
18-Month Brand Building: MensRx & WomensRx Recognition & Loyalty
Our dual-brand strategy is meticulously designed to cultivate strong brand recognition and unwavering customer loyalty for MensRx and WomensRx over the 18-month timeline. These brands are not just product labels; they are built from the ground up to exude brand recognition and brand loyalty, establishing a premium positioning in the telehealth market. This approach is rooted in providing a consistent brand experience across all digital and physical touchpoints, ensuring that customer retention and loyalty metrics strengthen significantly over the 18 months. By Month 18, our brand equity will have matured into a formidable, defensible moat, demonstrating that MensRx and WomensRx are built for long-term customer relationships, moving beyond transactional healthcare to fostering enduring trust and engagement.
Months 1-6: Establishing Identity & Premium Positioning
MensRx and WomensRx are designed from the ground up to exude brand recognition and brand loyalty, immediately establishing a premium positioning in the telehealth market. Our initial focus is on consistent brand experience across digital and physical touchpoints, laying the foundation for strong customer perception.
Months 7-12: Deepening Engagement & Loyalty
As our subscriber base grows, customer retention and loyalty metrics strengthen. We amplify our consistent brand experience through enhanced personalization and community building, actively fostering deeper relationships and increasing customer lifetime value. This phase solidifies the emotional connection with both brands.
Months 13-18: Brand Equity as a Defensible Moat
By Month 18, the collective brand equity of MensRx and WomensRx becomes a powerful, defensible moat against competitors. The brands are unequivocally built for long-term customer relationships, not transactional healthcare, securing a loyal customer base and demonstrating market leadership through sustained trust and recognition.
18-Month Roadmap: Capital Deployment & Series A Milestones
Months 0–3: Foundational Capital Deployment & Launch Readiness
Initial capital is deployed to acquire the MensRx.com domain, complete essential website builds, onboard PharmacyHub and technology partners, establish a robust legal and compliance foundation, submit LegitScript certifications, finalize the comprehensive product catalog, and initiate UGC creative production. This phase focuses on establishing a fully operational infrastructure ready for market entry.
Months 3–6: User Acquisition & CAC Optimization
Strategic capital is allocated to launch initial advertising campaigns aimed at acquiring our first 100–300 users. We will establish the Cost of Customer Acquisition (CAC) baseline, activate retention workflows, and rapidly scale to over 1,000 active customers. This phase prioritizes optimizing acquisition channels and expanding our product mix to drive early growth and validate unit economics.
Months 7–8: Break-Even Achievement & Self-Sustenance
Through disciplined capital management and user growth, we achieve 2,000–3,000 active subscribers. At this critical milestone, net revenue exceeds our operating burn rate, leading to profitability and entering the investor comfort zone with proven unit economics. Generated revenue is immediately reinvested to fuel accelerated, self-sustaining growth.
Months 9–12: Revenue-Fueled Exponential Growth & Expansion Planning
Leveraging reinvested profits, we scale to 5,000–7,000 active users, generating over $500,000 in monthly net revenue. This substantial cash flow enables identification of distressed medical marijuana buildings for future clinic conversion and initiates architectural planning for MensRx Clinic #1 in Florida, strategically deploying capital for physical expansion.
Months 12–15: Physical Clinic #1 Capital Investment & Launch
Approximately $275,000 of generated revenue is invested to acquire and convert the facility for MensRx Clinic #1. This phase focuses on building a reputation engine for in-person premium services and creating seamless cross-pollination between online and offline customer journeys, diversifying our service offering and deepening customer engagement.
Months 15–18: Omnichannel Platform & Series A Readiness
We launch WomensRx Clinic #1, reach 10,000+ active subscribers generating over $1.2M in monthly net revenue potential, and establish a robust multi-channel platform. Capital from sustained growth is utilized to build a comprehensive investor data room, prepare for a $20M–$50M Series A fundraising round, and activate a national PR campaign, positioning HealthPro Direct as a leading omnichannel healthcare provider.

By Month 18, HealthPro Direct transforms into a defensible omnichannel healthcare platform: 10,000+ active subscribers, 2 physical clinic locations, $1.2M+ monthly net revenue potential, proven repeatable CAC acquisition machine, massive defensible intellectual property portfolio, and prime positioning for $20M–$50M Series A funding.